Nina Bhardwaj, MD, PhD
img_Nina Bhardwaj
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Urology
PROFESSOR | Immunology & Immunotherapy
Research Topics
AIDS/HIV, Immunology
Multi-Disciplinary Training Area
Immunology [IMM]

MD, New York University School of Medicine

PhD, New York University School of Medicine

Internship, Brigham and Womens Hospital, Harvard Medical School,

New award

Cancer Precision Medicine Retreat -- Session 2: Nina Bhardwaj

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Bhardwaj during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Merck & Co., Inc.
  • Rone Therapeutics
  • carisma
  • curevac
  • Cell BioEngines
  • apriicty
  • Aikium

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • genotwin
  • Rone Therapeutics
  • apriicty
  • primevax
  • Breakbio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.